Live Breaking News & Updates on Health Systems Shontelle Dodson

Share this article
Share this article
NORTHBROOK, Ill. and BOSTON, Feb. 4, 2021 /PRNewswire/  Astellas announced the expansion of its Top Management to include two new positions today, both of which will report directly to Chief Executive Officer Kenji Yasukawa and serve as part of Astellas global executive committee:
Astellas US President
Percival Barretto-Ko was promoted to Chief Business Officer, focused on leading the company s new corporate strategic plan and enhancing Astellas external and internal innovation.
Astellas Institute for Regenerative Medicine President
Yoshitsugu Shitaka was promoted to Chief Scientific Officer, with responsibility for operations and the expansion of Astellas drug discovery research program platforms. He will also serve as Astellas President of its Drug Discovery Research (DDR) organization. ....

United States , Kenji Yasukawa , Yoshitsugu Shitaka , Steve Sabus , Astellas Pharma , Yukio Matsui , Mark Reisenauer , Percival Barretto Ko , Astellas Institute For Regenerative Medicine , Health Systems Shontelle Dodson , Transformation Office , Discovery Science Laboratory , Frontier Disease Research Unit , Drug Discovery Research , Discovery Research Unit , Research Portfolio Science , Bristol Myers Squibb , Modality Research Laboratory , Business Development , Top Management , Chief Executive Officer Kenji Yasukawa , Chief Business Officer , Chief Scientific Officer , Astella President , Advanced Informatics , Intellectual Property ,